Why America needs a strong FDA

JAMA

Volumn 294, Issue 19, 2005, Pages 2489-2491

  Markel, Howard ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL; MURAGLITAZAR; ORAL ANTIDIABETIC AGENT; ROFECOXIB;

ADVERTIZING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; DEREGULATION; DRUG APPROVAL; DRUG INDUSTRY; DRUG MARKETING; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEART INFARCTION; HUMAN; NOTE; PATENT; POLITICS; PRIORITY JOURNAL; STANDARD; UNITED STATES;

EID: 27744556191     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.19.2489     Document Type: Note

References (19)

1. Whitman W. By Blue Ontario's Shore. In: Leaves of Grass. New York, NY: Modern Library/Random House; 1959:269-281.
2. Buenker JD. Pure Food and Drug Act. In: Boyer PS, ed. The Oxford Companion to United States History. New York, NY: Oxford University Press; 2001:637-638.
3. Waxman HA. The lessons of Vioxx: drug safety and sales. N Engl J Med. 2005;352:2576-2578.
4. Brophy JM. Selling safety - lessons from muraglitazar. JAMA. Available at: http://jama.ama-assn.org/cgi/content/full/294.20.jed50074v1. Published online (early release) October 20, 2005. Accessed October 25, 2005.
5. Nissen SE, Wolski K, Topol EJ. Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus. JAMA. Available at: http://jama.ama-assn.org/cgi/content/full/294.20.joc50147v1. Published online (early release) October 20, 2005. Accessed October 25, 2005.
6. Angell M. The Truth About the Drug Companies: How They Deceive Us and What to Do About It. New York, NY: Random House; 2004.
7. Wood AJJ, Drazen JM, Greene MF. A sad day for science at the FDA. N Engl J Med. 2005;353:1197-1199.
8. Harris G. Ex-head of F.D.A. or wife sold stock in regulated area. New York Times. October 27, 2005. Available at: http://www.nytimes.com/2005/10/27/ politics/27fda.html. Accessed October 27, 2005.
9. Swann JP. History of the FDA. In: Kurian G, ed. The Historical Guide to American Government. New York, NY: Oxford University Press; 1988:248-254.
10. Hilts P. Protecting America's Health: The FDA, Business, and One Hundred Years of Regulation. New York, NY: Alfred A Knopf; 2003.
11. Young JH. Pure Food: Securing the Federal Food and Drugs Acts of 1906. Princeton, NJ: Princeton University Press; 1989.
12. Young JH. The Medical Messiahs: A Social History of Health Quackery in Twentieth Century America. Princeton, NJ: Princeton University Press; 1967.
13. Anderson OE Jr. The Health of a Nation: Harvey W. Wiley and the Fight for Pure Food. Chicago, Ill: University of Chicago Press; 1958.
14. Wiley HW. An Autobiography. Indianapolis, Ind: Bobbs-Merrill; 1930.
15. Adams SH. The Great American Fraud: A Series of Articles on the Patent Medicine Evil. Reprinted from Collier's Weekly. New York, NY: PF Collier & Son; 1905.
16. Sinclair U. The Jungle. New York, NY: Doubleday & Page; 1906.
17. Feulner EJ, ed. Mandate for Leadership: Policy Management in a Conservative Administration. Washington, DC: Heritage Foundation; 1980.
18. Kessler DA. A Question of Intent: A Great American Battle With a Deadly Industry. New York, NY: Public Affairs; 2001.
19. Interview with David Kessler. The Diane Rehm Show, National Public Radio. September 27, 2005. Available at: http://www.wamu.org/programs/dro5/09/27.php. Accessed October 13, 2005.